Latest Breaking News On - Vegan formulated - Page 13 : comparemela.com

Share: This Proposed Pharma Grade Version of Tauri-Gum™ is Being Developed Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment NEW YORK, NY, Dec. 16, 2020 (GLOBE NEWSWIRE) via NewMediaWire Tauriga Sciences, Inc. (OTCQB: TAUG) ( Tauriga or the Company ), a revenue generating, diversified life sciences company, with a proprietary line of functional supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced the resumption of clinical development efforts, concerning its proposed Anti-Nausea pharmaceutical grade version of Tauri-Gum™.  The Company expects to issue a material update to shareholders, within the near term (concerning the resumption of this Pharmaceutical Development Work).       

New yorkUnited statesComunidad autonoma de catalunaSethm shawDevelopment workAegea biotechnologies incNewmediawire tauriga sciences incExchange commissionStrategic allianceUnited states patent trademark officeTauriga sciences incProposed pharma grade versionBeing developed specificallyPatients subjectedBlood orangePear bellini